NEOS Investment Management LLC grew its holdings in Centene Corporation (NYSE:CNC – Free Report) by 42.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,210 shares of the company’s stock after purchasing an additional 20,185 shares during the quarter. NEOS Investment Management LLC’s holdings in Centene were worth $2,434,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Addison Advisors LLC raised its holdings in shares of Centene by 455.6% in the third quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after acquiring an additional 606 shares during the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Centene in the 3rd quarter valued at about $27,000. WPG Advisers LLC lifted its holdings in Centene by 44.5% in the 3rd quarter. WPG Advisers LLC now owns 915 shares of the company’s stock valued at $33,000 after purchasing an additional 282 shares in the last quarter. Bogart Wealth LLC boosted its stake in shares of Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after purchasing an additional 991 shares during the last quarter. Finally, Financial Network Wealth Advisors LLC grew its holdings in shares of Centene by 54.9% during the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock worth $39,000 after buying an additional 390 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on CNC shares. Robert W. Baird upped their price objective on shares of Centene from $28.00 to $36.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research note on Wednesday, January 21st. Wells Fargo & Company set a $44.00 price objective on Centene and gave the stock an “equal weight” rating in a report on Wednesday. Mizuho set a $47.00 target price on Centene in a research note on Friday, January 9th. Finally, TD Cowen raised their price target on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday, February 11th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $41.88.
Centene Stock Performance
Shares of NYSE:CNC opened at $43.61 on Friday. The firm has a market capitalization of $21.45 billion, a PE ratio of -3.20, a P/E/G ratio of 0.95 and a beta of 0.48. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $66.03. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.08. The business has a 50-day moving average of $42.39 and a two-hundred day moving average of $36.75.
Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same quarter in the previous year, the business earned $0.80 EPS. The company’s revenue for the quarter was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. As a group, research analysts forecast that Centene Corporation will post 6.86 earnings per share for the current year.
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Read More
- Five stocks we like better than Centene
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
